Related Experiment Video
Updated: Sep 12, 2026

Screening for Melanoma Modifiers using a Zebrafish Autochthonous Tumor Model
Published on: November 13, 2012
[Familial malignant melanoma]
1Department of Dermatology, Kobe University.
Abstract:
Patients with familial malignant melanoma(FMM) are susceptible for melanoma and multiple dysplastic nevi(atypical mole). FMM is also called as dysplastic nevus syndrome or familial atypical mole and melanoma syndrome. The number of Japanese patients with FMM is very low. In 1994, p16(MTS1, INK4A, CDK4I, CDKN2) gene was cloned as the gene for FMM. p16 gene locus also codes for p14ARF and acts as tumor suppressor through activation of Rb by p16 and p53 by p14ARF. Approximately 20% of FMM patients were shown to carry the germline mutations of p16, indicating the presence of another gene or other genes for FMM, which also may be involved in the development of sporadic malignant melanoma.
Insights
Familial malignant melanoma (FMM) is linked to the p16 gene, but mutations in this gene are found in only 20% of patients. This suggests other genetic factors contribute to FMM and potentially sporadic melanoma.
Area of Science:
- Oncology
- Genetics
- Dermatology
Context:
- Familial malignant melanoma (FMM), also known as dysplastic nevus syndrome, is a rare genetic condition.
- Patients with FMM have an increased susceptibility to melanoma and multiple atypical moles.
- The p16 gene (MTS1, INK4A, CDK4I, CDKN2) was identified as a key gene associated with FMM.
Purpose:
- To investigate the genetic basis of familial malignant melanoma (FMM).
- To understand the role of the p16 gene and its locus in melanoma development.
- To explore potential genetic links between FMM and sporadic melanoma.
Summary:
- Germline mutations in the p16 gene are identified in approximately 20% of FMM patients.
- The p16 gene locus also encodes p14ARF, both acting as tumor suppressors.
- The low prevalence of p16 mutations suggests other genes are involved in FMM pathogenesis.
Impact:
- Identifies the p16 gene as a significant, but not sole, contributor to FMM.
- Highlights the potential role of other FMM-associated genes in sporadic melanoma development.
- Provides a foundation for further research into the genetic landscape of melanoma.
Related Concept Videos
Abnormal Proliferation
Cancers Originate from Somatic Mutations in a Single Cell
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...

